We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

mTor-inhibitor (EVERolimus) Based Immunosuppressive Strategies for CNI Minimisation in OLD for Old Renal Transplantation (EVEROLD)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01028092
First Posted: December 9, 2009
Last Update Posted: July 8, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Novartis
Roche Pharma AG
Genzyme, a Sanofi Company
Ministry of Health, France
Information provided by (Responsible Party):
University Hospital, Brest
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2014
  Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)